Generated: April 29, 2017
|Abstract:||Compounds of Formula 1 [R.sub.egion .alpha.]--[R.sub.egion .beta.]--[R.sub.egion .gamma.]--[R.sub.egion .delta.] (1) which are useful as modulators of chemokine activity. The invention also provides pharmaceutical formulations and methods of treatment using these compounds.|
|Inventor(s):||Armour; Duncan Robert (Ramsgate, GB), Price; David Anthony (Ringwould Deal, GB), Stammen; Blanda Luzia Christa (Sandwich, GB), Wood; Anthony (Margate, GB), Perros; Manoussos (Ramsgate, GB), Edwards; Martin Paul (Ringwould Deal, GB)|
|Assignee:||Pfizer, Inc. (New York, NY)|
|Filing Date:||Dec 01, 1999|
|Claims:||1. A compound which is selected from ##STR00144## ##STR00145## ##STR00146## ##STR00147## ##STR00148## and the pharmaceutically acceptable salts thereof.|
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.